Benjamin Bonavida

Author detail

24 featured books

Bookitis has not yet captured a biography for this author, but the catalog links below show the books currently associated with this profile.

Search this author Open first work

OL3143025A

Overview

Catalog identity and bibliographic footprint for this author.

24 representative editions

Author pages in Bookitis are intended to show only works actually attributed to the author and a representative edition for each of those works.

Catalog identity

How this author appears inside the active Bookitis catalog.

Display name
Benjamin Bonavida
Source identifier
OL3143025A

Featured books

Representative editions for works actually authored by this person.

SA
Image source: Open Library
Successes and Challenges of NK Immunotherapy
Successes and Challenges of NK Immunotherapy | 2021
Representative edition for this work grouping in the active catalog.
cover
NO
Image source: Open Library
Nitric Oxide and Cancer
Nitric Oxide and Cancer | 2016
Representative edition for this work grouping in the active catalog.
cover
RO
Image source: Open Library
Resistance of Cancer Cells to CTL-Mediated Immunotherapy
Resistance of Cancer Cells to CTL-Mediated Immunotherapy | 2016
Representative edition for this work grouping in the active catalog.
cover
MM
Image source: Open Library
Molecular Mechanisms Of Tumor Cell Resistance To Chemotherapy Targeted Therapies To Reverse Resistance
Molecular Mechanisms Of Tumor Cell Resistance To Chemotherapy Targeted Therapies To Reverse Resistance | 2013
Representative edition for this work grouping in the active catalog.
cover
RT
Image source: Open Library
Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer Therapeutics
Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer Therapeutics | 2013
Representative edition for this work grouping in the active catalog.
cover
NO
Image source: Open Library
Nitric Oxide (NO) and Cancer
Nitric Oxide (NO) and Cancer | 2010
Representative edition for this work grouping in the active catalog.
cover
SO
Image source: Open Library
Sensitization of cancer cells for chemo/immuno/radio-therapy
Sensitization of cancer cells for chemo/immuno/radio-therapy | 2008
Representative edition for this work grouping in the active catalog.
cover
TN
Image source: Open Library
Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy
Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy | 1990
Representative edition for this work grouping in the active catalog.
cover
MC
Image source: Open Library
Membrane-mediated cytotoxicity
Membrane-mediated cytotoxicity | 1987
Representative edition for this work grouping in the active catalog.
cover
Therapeutic Applications of Nit...Benjamin Bonavida
TA
Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disease
Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disease | 2024
Representative edition for this work grouping in the active catalog.
no cover
Nitric Oxide in Health and DiseaseBenjamin Bonavida
NO
Nitric Oxide in Health and Disease
Nitric Oxide in Health and Disease | 2023
Representative edition for this work grouping in the active catalog.
no cover
Overcoming Cancers Resistant to...Benjamin Bonavida
OC
Overcoming Cancers Resistant to HER-2 Antibodies
Overcoming Cancers Resistant to HER-2 Antibodies | 2020
Representative edition for this work grouping in the active catalog.
no cover
New Combination Approaches to E...Benjamin Bonavida
NC
New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies
New Combination Approaches to Enhance Rituximab-Based Lymphoma Therapies | 2020
Representative edition for this work grouping in the active catalog.
no cover
Prognostic and Therapeutic Appl...Benjamin Bonavida
PA
Prognostic and Therapeutic Applications of RKIP in Cancer
Prognostic and Therapeutic Applications of RKIP in Cancer | 2020
Representative edition for this work grouping in the active catalog.
no cover
YY1 Is Pivotal in the Control o...Benjamin Bonavida
YI
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of Cancer
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of Cancer | 2020
Representative edition for this work grouping in the active catalog.
no cover
Breaking Tolerance to Pancreati...Benjamin Bonavida
BT
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy | 2019
Representative edition for this work grouping in the active catalog.
no cover
Therapeutic Application of Nitr...Benjamin Bonavida
TA
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders
Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders | 2019
Representative edition for this work grouping in the active catalog.
no cover
Improving the Therapeutic Ratio...Benjamin Bonavida
IT
Improving the Therapeutic Ratio in Head and Neck Cancer
Improving the Therapeutic Ratio in Head and Neck Cancer | 2019
Representative edition for this work grouping in the active catalog.
no cover
Nitric Oxide (Donor/Induced) in...Benjamin Bonavida
NO
Nitric Oxide (Donor/Induced) in Chemosensitization
Nitric Oxide (Donor/Induced) in Chemosensitization | 2018
Representative edition for this work grouping in the active catalog.
no cover
Role of Nutraceuticals in Cance...Benjamin Bonavida
RO
Role of Nutraceuticals in Cancer Chemosensitization
Role of Nutraceuticals in Cancer Chemosensitization | 2018
Representative edition for this work grouping in the active catalog.
no cover
Protein Kinase Inhibitors As Se...Benjamin Bonavida
PK
Protein Kinase Inhibitors As Sensitizing Agents for Chemotherapy
Protein Kinase Inhibitors As Sensitizing Agents for Chemotherapy | 2018
Representative edition for this work grouping in the active catalog.
no cover
Targeting Cell Survival Pathway...Benjamin Bonavida
TC
Targeting Cell Survival Pathways to Enhance Response to Chemotherapy
Targeting Cell Survival Pathways to Enhance Response to Chemotherapy | 2018
Representative edition for this work grouping in the active catalog.
no cover
Nitric Oxide As a Chemosensitiz...Benjamin Bonavida
NO
Nitric Oxide As a Chemosensitizing Agent
Nitric Oxide As a Chemosensitizing Agent | 2017
Representative edition for this work grouping in the active catalog.
no cover
Resistance to Immunotoxins in C...Benjamin Bonavida
RT
Resistance to Immunotoxins in Cancer Therapy
Resistance to Immunotoxins in Cancer Therapy | 2016
Representative edition for this work grouping in the active catalog.
no cover

Works in catalog

Quick navigation into the work-level grouping pages behind the featured books.